Pediatrix Medical (MD) Cash from Operations (2009 - 2026)

Pediatrix Medical (MD) has reported Cash from Operations for 18 consecutive years, with $125.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Operations fell 10.15% year-over-year to $125.3 million in Q2 2026; TTM through Jun 2026 was $248.2 million, a 3.63% decrease from a year earlier, with the FY2025 full-year figure at $274.7 million, up 26.46% from the prior year.
• Cash from Operations was $125.3 million for Q2 2026 at Pediatrix Medical, up from -$129.8 million in the prior quarter.
• Over five years, Cash from Operations peaked at $139.5 million in Q2 2025 and troughed at -$129.8 million in Q1 2026.
• A 5-year average of $45.3 million and a median of $92.1 million in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations slipped 28.63% in 2023 and soared 84.66% in 2024, its largest moves.
• Over 5 years, Cash from Operations stood at $102.3 million in 2022, then declined by 28.63% to $73.0 million in 2023, then soared by 84.66% to $134.8 million in 2024, then fell by 14.99% to $114.6 million in 2025, then rose by 9.35% to $125.3 million in 2026.
• The last three Cash from Operations figures came in at $125.3 million (Q2 2026), -$129.8 million (Q1 2026), and $114.6 million (Q4 2025), per Business Quant data.